March 6 (Reuters) - Telehealth firms Teladoc

and LifeMD ( LFMD ) said on Thursday they had signed an

agreement with Gifthealth, the pharmacy partner of Eli Lilly's ( LLY )

direct-to-consumer site, LillyDirect, to offer patients

the weight-loss drug, Zepbound.

Telehealth companies have previously offered compounded

versions of weight-loss treatments when the drugs were in

shortage.

However, with the U.S. Food and Drug Administration removing

the popular drugs from its shortage list, compounding pharmacies

will no longer be able to sell the cheaper copies in the coming

months.

Last week, Lilly cut the price of Zepbound vials by $50 or

more and expanded the range of doses sold online through

LillyDirect.

The agreement with Gifthealth allows eligible members to

gain access to single-use vials that can be delivered directly

to their homes, Teladoc said.